ICU Medical, Inc.
ICUI
Market Cap$3.24B
Close$
$291.64
120.7% upside
Current Fair Value
120.7% upsideUndervalued by 120.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.24 Billion |
|---|---|
| Enterprise Value | $4.69 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.83 |
| Beta | 0.89 |
| Outstanding Shares | 24,539,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -34.52 |
|---|---|
| PEG | 56.79 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 1.94 |
| Enterprise Value to EBIT | 59.92 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ICU Medical, Inc.
9,000 employees
CEO: Vivek Jain ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...